We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHH icon
176
Schwab US REIT ETF
SCHH
$11.3B
$368K 0.03%
18,116
– –
GE icon
177
GE Aerospace
GE
$355B
$368K 0.03%
+2,625
New +$309K
IEMG icon
178
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
$357K 0.03%
6,927
– –
TAK icon
179
Takeda Pharmaceutical
TAK
$57.6B
$354K 0.03%
25,461
+12,010
+89% +$175K
QCOM icon
180
Qualcomm
QCOM
$175B
$353K 0.03%
2,088
+501
+32% +$77.4K
LRGF icon
181
iShares US Equity Factor ETF
LRGF
$3.71B
$348K 0.03%
6,471
+2
+0% +$102
ALC icon
182
Alcon
ALC
$34.8B
$347K 0.03%
+4,165
New +$334K
MFG icon
183
Mizuho Financial
MFG
$129B
$345K 0.03%
86,779
+65,963
+317% +$246K
AZN icon
184
AstraZeneca
AZN
$252B
$344K 0.03%
2,541
-875
-26% -$116K
STLA icon
185
Stellantis
STLA
$20.4B
$344K 0.03%
+12,162
New +$303K
GILD icon
186
Gilead Sciences
GILD
$181B
$344K 0.03%
4,691
+62
+1% +$4.77K
MFC icon
187
Manulife Financial
MFC
$70.9B
$340K 0.03%
+13,609
New +$313K
SMFG icon
188
Sumitomo Mitsui Financial
SMFG
$164B
$340K 0.03%
28,882
+14,642
+103% +$157K
UBER icon
189
Uber
UBER
$161B
$335K 0.03%
+4,349
New +$312K
VB icon
190
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$332K 0.03%
1,452
– –
CNI icon
191
Canadian National Railway
CNI
$76.2B
$327K 0.03%
2,486
+762
+44% +$97.4K
LRCX icon
192
Lam Research
LRCX
$378B
$325K 0.03%
+3,340
New +$294K
DD icon
193
DuPont de Nemours
DD
$18.5B
$324K 0.03%
3,363
+330
+11% +$29.4K
SDY icon
194
State Street SPDR S&P Dividend ETF
SDY
$22B
$319K 0.03%
2,433
+13
+0.5% +$1.63K
UNP icon
195
Union Pacific
UNP
$183B
$318K 0.03%
1,292
+141
+12% +$34.7K
WFC icon
196
Wells Fargo
WFC
$262B
$317K 0.03%
+5,462
New +$286K
ED icon
197
Consolidated Edison
ED
$39.8B
$313K 0.03%
3,452
+726
+27% +$65.1K
RCL icon
198
Royal Caribbean
RCL
$74.7B
$313K 0.03%
2,250
+29
+1% +$3.62K
BMY icon
199
Bristol-Myers Squibb
BMY
$136B
$310K 0.03%
+5,718
New +$291K
KO icon
200
Coca-Cola
KO
$386B
$309K 0.03%
5,054
+1,261
+33% +$75.7K
6 7
8
9 10

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.